Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Study design
1.1.2. Indication
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Virtual/Decentralized Clinical Trials Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. COVID-19 pandemic impact on clinical trial activity
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. The growing role technology in the healthcare
3.4.1.2. Benefits of virtual trials
3.4.1.3. Government support
3.4.2. Market Restraint Analysis
3.4.2.1. Data Security
3.4.3. Industry Challenge
3.5. Virtual/Decentralized Clinical Trials Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
Chapter 4. Virtual/Decentralized Clinical Trials Market: Segment Analysis, By Study Design, 2016 - 2028 (USD Million)
4.1. Segment Dashboard
4.2. Study Design Market Share Analysis, 2020 & 2028
4.3. Global Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 to 2028
4.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.4.1. Interventional
4.4.2. Observational
4.4.3. Expanded Access
Chapter 5. Virtual/Decentralized Clinical Trials Market: Segment Analysis, By Indication, 2016 - 2028 (USD Million)
5.1. Segment Dashboard
5.2. Indication Market Share Analysis, 2020 & 2028
5.3. Global Virtual/Decentralized Clinical Trials Market, By Cancer Type, 2016 to 2028
5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.4.1. Oncology
5.4.2. Cardiovascular
5.4.3. Others
Chapter 6. Virtual/Decentralized Clinical Trials Market: Regional Market Analysis, By Study Design, 2016 - 2028 (USD Million)
6.1. Regional Market Dashboard
6.2. Regional Market Share Analysis, 2020 & 2028
6.3. Market Size, & Forecasts, and Trend Analysis, 2016 to 2028:
6.4. North America
6.4.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
6.4.2. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.4.3. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.4.4. U.S.
6.4.4.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.4.4.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.4.5. Canada
6.4.5.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.4.5.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.5. Europe
6.5.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
6.5.2. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.5.3. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.5.4. Germany
6.5.4.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.5.4.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.5.5. U.K.
6.5.5.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.5.5.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.5.6. France
6.5.6.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.5.6.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.5.7. Italy
6.5.7.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.5.7.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.5.8. Spain
6.5.8.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.5.8.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.6. Asia Pacific
6.6.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
6.6.2. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.6.3. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.6.4. India
6.6.4.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.6.4.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.6.5. Japan
6.6.5.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.6.5.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.6.6. China
6.6.6.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.6.6.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.6.7. Australia
6.6.7.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.6.7.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.6.8. South Korea
6.6.8.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.6.8.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.7. Latin America
6.7.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
6.7.2. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.7.3. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.7.4. Brazil
6.7.4.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.7.4.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.7.5. Mexico
6.7.5.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.7.5.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.7.6. Argentina
6.7.6.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.7.6.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.7.7. Colombia
6.7.7.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.7.7.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.8. Middle East and Africa
6.8.1. Market estimates and forecast, by country, 2016 - 2028 (USD Million)
6.8.2. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.8.3. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.8.4. South Africa
6.8.4.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.8.4.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.8.5. Saudi Arabia
6.8.5.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.8.5.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
6.8.6. UAE
6.8.6.1. Market estimates and forecast, by study design, 2016 - 2028 (USD Million)
6.8.6.2. Market estimates and forecast, by indication, 2016 - 2028 (USD Million)
Chapter 7. Virtual/Decentralized Clinical Trials Market- Competitive Analysis
7.1. Key companies profiled
7.1.1. ICON, plc
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. Parexel International Corporation
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. IQVIA
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. Covance
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. PRA Health Sciences
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. LEO Innovation Lab
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. Medidata
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. Oracle
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. CRF Health
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. Clinical Ink, Inc.
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
7.1.11. Medable, Inc.
7.1.11.1. Company Overview
7.1.11.2. Financial Performance
7.1.11.3. Product Benchmarking
7.1.11.4. Strategic Initiatives



List of Figures



Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Virtual/decentralized clinical trials market: Market snapshot
Fig. 9 Virtual/decentralized clinical trials market: Market segmentation
Fig. 10 Virtual/decentralized clinical trials market strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Virtual/decentralized clinical trials market driver impact
Fig. 14 Virtual/decentralized clinical trials market restraint impact
Fig. 15 Virtual/decentralized clinical trials market porter’s five forces analysis
Fig. 16 Virtual/decentralized clinical trials market PESTEL analysis
Fig. 17 Virtual/decentralized clinical trials market: study design segment dashboard
Fig. 18 Virtual/decentralized clinical trials market: Study design movement analysis
Fig. 19 Interventional market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 20 Observational market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 21 Expanded Access market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 22 Virtual/decentralized clinical trials market: Indication segment dashboard
Fig. 23 Virtual/decentralized clinical trials market: Indication movement analysis
Fig. 24 Oncology market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 25 Cardiovascular market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 26 Others market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 27 Global virtual/decentralized clinical trials market: Regional movement analysis
Fig. 28 Global virtual/decentralized clinical trials market: Regional outlook and key takeaways
Fig. 29 North America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 30 U.S. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 31 Canada market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 32 Europe market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 33 U.K. market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 34 Germany market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 35 France market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 36 Italy market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 37 Spain market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 38 Asia Pacific market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 39 India market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 40 Japan market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 41 China market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 42 Australia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 43 South Korea market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 44 Latin America market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 45 Brazil market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 46 Mexico market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 47 Argentina market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 48 Colombia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 49 Middle East and Africa market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 50 South Africa market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 51 Saudi Arabia market estimates and forecast, 2016 - 2028 (USD Million)
Fig. 52 UAE market estimates and forecast, 2016 - 2028 (USD Million)


List of Tables



Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Virtual/Decentralized Clinical Trials Market, By Region, 2016 - 2028 (USD Million)
Table 4 Global Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 5 Global Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 6 North America Virtual/Decentralized Clinical Trials Market, By Country, 2016 - 2028 (USD Million)
Table 7 North America Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 8 North America Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 9 U.S. Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 10 U.S. Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 11 Canada Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 12 Canada Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 13 Europe Virtual/Decentralized Clinical Trials Market, By Country, 2016 - 2028 (USD Million)
Table 14 Europe Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 15 Europe Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 16 U.K. Virtual Clinical/Decentralized Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 17 U.K. Virtual Clinical/Decentralized Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 18 Germany Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 19 Germany Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 20 France Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 21 France Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 22 Italy Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 23 Italy Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 24 Spain Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 25 Spain Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 26 Asia Pacific Virtual/Decentralized Clinical Trials Market, By Country, 2016 - 2028 (USD Million)
Table 27 Asia Pacific Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 28 Asia Pacific Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 29 India Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 30 India Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 31 Japan Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 32 Japan Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 33 China Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 34 China Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 35 Australia Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 36 Australia Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 37 South Korea Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 38 South Korea Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 39 Latin America Virtual/Decentralized Clinical Trials Market, By Country, 2016 - 2028 (USD Million)
Table 40 Latin America Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 41 Latin America Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 42 Brazil Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 43 Brazil Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 44 Mexico Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 45 Mexico Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 46 Argentina Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 47 Argentina Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 48 Colombia Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 49 Colombia Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 50 MEA Virtual/Decentralized Clinical Trials Market, By Country, 2016 - 2028 (USD Million)
Table 51 MEA Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 52 MEA Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 53 South Africa Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 54 South Africa Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 55 Saudi Arabia Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 56 Saudi Arabia Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)
Table 57 UAE Virtual/Decentralized Clinical Trials Market, By Study Design, 2016 - 2028 (USD Million)
Table 58 UAE Virtual/Decentralized Clinical Trials Market, By Indication, 2016 - 2028 (USD Million)